Indications and uses
for relief of occasional constipation and irregularity this product generally produces bowel movement in 12 to 72 hours
for relief of occasional constipation and irregularity this product generally produces bowel movement in 12 to 72 hours
take with a glass of water adults and children 12 years and over take 1-3 softgels daily. This dose may be taken as a single daily dose or in divided doses. children 2 to under 12 years of age take 1 softgel daily children under 2 years ask a doctor
each softgel contains: sodium 7 mg store at 25ºC (77ºF); excursion permitted between 15-30ºC (59-86ºF)
Docusate Sodium USP, 100 mg
Stool softener laxative
if you are presently taking mineral oil, unless told to do so by a doctor.
ask a health care professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-2222-1222) right away.
| adults and children 12 years and over | take 1-3 softgels daily. This dose may be taken as a single daily dose or in divided doses. |
| children 2 to under 12 years of age | take 1 softgel daily |
| children under 2 years | ask a doctor |
citric acid, FD&C Red #40, FD&C Yellow #6, gelatin, glycerin, polyethylene glycol, propylene glycol, purified water, sorbitol special, white edible ink
Call 1-877-753-3935 Monday-Friday 9AM-5PM EST
Compare to Dulcolax® active ingredient*
Regular Strength
STOOL SOFTENER LAXATIVE
Docusate Sodium, 100 mg
Relieves Occasional Constipation
Stimulant Free
SOFTGELS
*This product is not manufactured or distributed by Chattem, Inc., distributor of Dulcolax®.
TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.
Distributed by:
CVS Pharmacy, Inc.
One CVS Drive,
Woonsocket, RI 02895
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3c386306-c48a-413e-bb69-70cb268496f3 | Product name | 1 | 20210727 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51316-107-10 | Stool Softener Laxative | 100 in 1 BOTTLE, PLASTIC | CAPSULE, LIQUID FILLED | 100 | 5 | |
| 51316-107-25 | Stool Softener Laxative | 1 in 1 BOX | CAPSULE, LIQUID FILLED | 1 | 5 | |
| 51316-107-25 | Stool Softener Laxative | 25 in 1 BOTTLE, PLASTIC | CAPSULE, LIQUID FILLED | 25 | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51316-107 | 51316-107-25, 51316-107-10 |
| 53345-008 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| GELATIN | 2G86QN327L | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SORBITOL | 506T60A25R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| SORBITAN | 6O92ICV9RU | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Laxative | DOCUSATE SODIUM | CVS PHARMACY, INC | 056ec3cf-edcf-4a9a-8cfa-7cf9c4a9a138 | 2026-05-20 | Warnings | 51316-107-10 51316-107-25 51316-107 51316010725 51316010710 e8090087-73dd-4918-b9eb-deeae979b765 056ec3cf-edcf-4a9a-8cfa-7cf9c4a9a138 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | b10fdf50-289e-41f3-9b83-a4e4dd892f88 | 2024-11-21 | Warnings | 53345-008 |
Adverse event summaries are temporarily unavailable. Other product information remains available.